PEG-Graft Density Controls Polymeric Nanoparticle Micelle Stability
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Polymeric nanoparticle micelles typically comprise amphiphilic block copolymers, having a hydrophobic core that is useful for chemotherapeutic encapsulation, and a hydrophilic corona for aqueous stability. Formulations often require the use of excipients to overcome poor particle stability, yet these excipients can be cytotoxic. In order to create a stable polymeric nanoparticle micelle without the use of excipients, we investigate a series of amphiphilic polymers where the hydrophobic core composition and molar mass is maintained and the hydrophilic corona is varied. With the graft copolymer, poly(d,l-lactide-co-2-methyl-2-carboxytrimethylenecarbonate)-g-poly(ethylene glycol) (P(LA-co-TMCC)-g-PEG), we demonstrate how PEG density can be tuned to improve the stability of the resulting self-assembled micelle. Increased PEG density leads to micelles that resist aggregation during lyophilization, allowing resuspension in aqueous media with narrow distribution. Furthermore, high PEG density micelles resist dissociation in serum protein containing media, with almost no dissociation seen in serum after 72 h. By changing the number of PEG chains per polymer backbone from 0.5 to 6, we observe increased stability of the nanoparticle micelles. All formulations are cytocompatible, as measured with MDA-MB-231 cells, and show no evidence for hemolysis, as measured with red blood cells. Importantly, PEG density does not impact drug loading within the nanoparticle micelle core, as demonstrated with the potent chemotherapeutic drug, docetaxel, confirming the role of the hydrophobic core for encapsulation. The surface properties of the polymeric nanoparticle micelles can thus be selectively modulated by variation in PEG density, which in turn influences stability, obviates the need for excipients and provides key insights into the design of drug delivery platforms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEG with molecular weights ranging from 1 to 6 kDa are an ideal molecular weight for endowing nanoparticles with efficient anti-fouling properties and are frequently being employed to prepare block copolymers for drug delivery [34, 69, 70].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [34]
In the citing paper
“In agreement with the results obtained on solid polymeric nanoparticles [61], a hydrophilic and neutral surface reduces the formation of the protein corona [62] and increase the circulation time after intravenous injection.”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [61]
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Abuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Owen, S. C., Chan, D. P. Y., & Shoichet, M. S. (2012) · Nano Today · doi:10.1016/j.nantod.2012.01.002 · Cited by 911
Self-citationFoged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., Napier, M., Bear, J. E., & DeSimone, J. M. (2012) · Nano Letters · doi:10.1021/nl302638g · Cited by 606
PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood Circulation
Prencipe, G., Tabakman, S. M., Welsher, K., Liu, Z., Goodwin, A. P., Zhang, L., Henry, J., & Dai, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809086q · Cited by 600
Pharmacological Effects of Formulation Vehicles: Implications for Cancer Chemotherapy
ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00005 · Cited by 591
Advances and challenges in smart and functional polymer vesicles
Du, J., & O'Reilly, R. K. (2009) · Soft Matter · doi:10.1039/b905635a · Cited by 572
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Kim, S., Shi, Y., Kim, J. Y., Park, K., & Cheng, J.-X. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903380446 · Cited by 549
Targeted polymeric micelles for delivery of poorly soluble drugs
Torchilin, V. P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4153-5 · Cited by 543
Kingshott, P., Thissen, H., & Griesser, H. J. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00334-9 · Cited by 537
PEG conjugates in clinical development or use as anticancer agents: An overview
Pasut, G., & Veronese, F. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.010 · Cited by 457
Controlling drug nanoparticle formation by rapid precipitation
D'Addio, S. M., & Prud'homme, R. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.04.005 · Cited by 392
Recent developments in the understanding of colloid stability
Overbeek, J. T. G. (1977) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(77)90151-5 · Cited by 362
Advances in PEGylation of important biotech molecules: delivery aspects
Ryan, S. M., Mantovani, G., Wang, X., Haddleton, D. M., & Brayden, D. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.371 · Cited by 323
Mixed micelles self-assembled from block copolymers for drug delivery
Ebrahim Attia, A. B., Ong, Z. Y., Hedrick, J. L., Lee, P. P., Ee, P. L. R., Hammond, P. T., & Yang, Y.-Y. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.10.003 · Cited by 315
Chen, H., Kim, S., He, W., Wang, H., Low, P. S., Park, K., & Cheng, J.-X. (2008) · Langmuir · doi:10.1021/la703570m · Cited by 311
Li, Y., He, H., Jia, X., Lu, W.-L., Lou, J., & Wei, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.004 · Cited by 310
Cho, H.-J., Yoon, H. Y., Koo, H., Ko, S.-H., Shim, J.-S., Lee, J.-H., Kim, K., Chan Kwon, I., & Kim, D.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.028 · Cited by 304
Stability of Self-Assembled Polymeric Micelles in Serum
Lu, J., Owen, S. C., & Shoichet, M. S. (2011) · Macromolecules · doi:10.1021/ma200675w · Cited by 299
Self-citationImproving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
Murakami, M., Cabral, H., Matsumoto, Y., Wu, S., Kano, M. R., Yamori, T., Nishiyama, N., & Kataoka, K. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001385 · Cited by 262
Liposome—complement interactions in rat serum: implications for liposome survival studies
Devine, D. V., Wong, K., Serrano, K., Chonn, A., & Cullis, P. R. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90231-3 · Cited by 248
Shi, Y., van Steenbergen, M. J., Teunissen, E. A., Novo, L., Gradmann, S., Baldus, M., van Nostrum, C. F., & Hennink, W. E. (2013) · Biomacromolecules · doi:10.1021/bm400234c · Cited by 222
Colloidal stability of Pluronic F68-coated PLGA nanoparticles: A variety of stabilisation mechanisms
Santander-Ortega, M. J., Jódar-Reyes, A. B., Csaba, N., Bastos-González, D., & Ortega-Vinuesa, J. L. (2006) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2006.07.031 · Cited by 221
Savić, R., Azzam, T., Eisenberg, A., & Maysinger, D. (2006) · Langmuir · doi:10.1021/la0531998 · Cited by 191
Ding, H.-M., & Ma, Y.-Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.055 · Cited by 180
Mikhail, A. S., & Allen, C. (2010) · Biomacromolecules · doi:10.1021/bm100073s · Cited by 180
Nanoparticles disguised as red blood cells to evade the immune system
Fang, R. H., Hu, C.-M. J., & Zhang, L. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.661710 · Cited by 174
Jaeghere, F. D., Allémann, É., Leroux, J., Stevels, W. M., Feijén, J., Doelker, É., & Gurny, R. (1999) · Pharmaceutical Research · doi:10.1023/a:1018826103261 · Cited by 155
Donini, C., Robinson, D. N., Colombo, P., Giordano, F., & Peppas, N. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00335-6 · Cited by 146
Surface Properties of Pluronic-Coated Polymeric Colloids
Li, J.-T., Caldwell, K. D., & Rapoport, N. Y. (1994) · Langmuir · doi:10.1021/la00024a016 · Cited by 134
Immuno‐Polymeric Nanoparticles by Diels–Alder Chemistry
Shi, M., Wosnick, J. H., Ho, K., Keating, A., & Shoichet, M. S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701032 · Cited by 126
Self-citationLu, J., Shi, M., & Shoichet, M. S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8003167 · Cited by 120
Self-citationGonzález, R. C. B., Huwyler, J., Boess, F., Walter, I., & Bittner, B. (2004) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.383 · Cited by 100
Zhao, X., Poon, Z., Engler, A. C., Bonner, D. K., & Hammond, P. T. (2012) · Biomacromolecules · doi:10.1021/bm201873u · Cited by 88
Flanary, S., Hoffman, A. S., & Stayton, P. S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800317a · Cited by 87
Thermodynamic limits on drug loading in nanoparticle cores
Kumar, V., & Prud’homme, R. K. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21342 · Cited by 87
Shahin, M., & Lavasanifar, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.015 · Cited by 86
Izutsu, K., Yoshioka, S., Kojima, S., Randolph, T. W., & Carpenter, J. F. (1996) · Pharmaceutical Research · doi:10.1023/a:1016086319851 · Cited by 80
Sun, Y., Zou, W., Bian, S., Huang, Y., Tan, Y., Liang, J., Fan, Y., & Zhang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.032 · Cited by 77
Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours
Cegnar, M., Kristl, J., & Kos, J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.12.1557 · Cited by 73
To PEGylate or not to PEGylate, that is not the question
Park, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.025 · Cited by 70
Diezi, T. A., Bae, Y., & Kwon, G. S. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100069p · Cited by 64
Patel, S. K., Lavasanifar, A., & Choi, P. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.060 · Cited by 54
Adams, M. L., & Kwon, G. S. (2002) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856202760319144 · Cited by 48
Freeze-Drying of Composite Core-Shell Nanoparticles
Layre, A., Couvreur, P., Richard, J., Requier, D., Ghermani, N., & Gref, R. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600685134 · Cited by 44
Lu, J., & Shoichet, M. S. (2010) · Macromolecules · doi:10.1021/ma1004265 · Cited by 42
Self-citationDouble Click: Dual Functionalized Polymeric Micelles with Antibodies and Peptides
Chan, D. P. Y., Owen, S. C., & Shoichet, M. S. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300511a · Cited by 39
Self-citationChan, D. P. Y., Deleavey, G. F., Owen, S. C., Damha, M. J., & Shoichet, M. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.019 · Cited by 38
Self-citationShi, M., & Shoichet, M. S. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208785540127 · Cited by 35
Self-citationHandbook of Materials for Nanomedicine
Torchilin, V. P. (2010) · Pan Stanford eBooks · doi:10.1201/b11121 · Cited by 31
Research works printed but not linked: 4
- Kataoka, 2012, Adv. Drug Deliver Rev., 1
- Kim, 2013, Macromolecules, 46, 6624
- Sawant, 2010, Methods Mol. Biol., 131
- Otsuka, 2012, Adv. Drug Delivery Rev., 1
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Pelaz, B., del Pino, P., Maffre, P., Hartmann, R., Gallego, M., Rivera-Fernández, S., de la Fuente, J. M., Nienhaus, G. U., & Parak, W. J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01326 · Cited by 890
“PEGylation, however, confers colloidal stability to NPs via steric repulsion, even under high salt conditions.(57)”
BackgroundHwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
“PEG with molecular weights ranging from 1 to 6 kDa are an ideal molecular weight for endowing nanoparticles with efficient anti-fouling properties and are frequently being employed to prepare block copolymers for drug delivery [34,69,70].”
BackgroundDe, R., Mahata, M. K., & Kim, K. (2022) · Advanced Science · doi:10.1002/advs.202105373 · Cited by 297
Metadata
- Authors
- Logie, J., Owen, S. C., McLaughlin, C. K., & Shoichet, M. S.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Shoichet, Molly S.
- Venue
- Chemistry of Materials
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-04-14
- Volume
- 26
- Issue
- 9
- Pages
- 2847-2855
- ISSN
- 0897-4756 (ISSN-L)
- 1520-5002
- OpenAlex
- W2156729636
- Cited by
- 110
- References
- 68
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 7 · 2021: 12 · 2020: 11 · 2019: 8 · 2018: 8 · 2017: 13 · 2016: 8 · 2015: 10 · 2014: 1
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Chemistry of Materials (publishedVersion, other-oa)
- Funders
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Keywords
- amphiphilic block copolymers, micelle stability, cytocompatibility, hemocompatibility, drug delivery systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.